Mutating basic amino acids or truncation in the C2 domain of PTEN in vitro leads to loss of tumor suppressing activities and the phosphatase activities (Georgescu et al. 1999, 2000; Lee et al. 1999). This evidence concerns the gene PTEN and neoplasm.